Place of human amniotic membrane immunoblotting in the diagnosis of autoimmune bullous dermatoses

British Journal of Dermatology

Volumn 162, Issue 4, 2010, Pages 743-750

  Grootenboer Mignot, S ^a,b   Descamps, V ^a,b   Picard Dahan, C ^a,b   Nicaise Roland, P ^a   Prost Squarcioni, C ^b,c   Leroux Villet, C ^b,c   Champagnat, C ^a   Delaval, A ^a   Aucouturier, F ^b,d   Crickx, B ^a,b   Chollet Martin, S ^a,e  

^a BICHAT HOSPITAL   (France)

^b Centre de Reference sur les Dermatoses Bulleuses Auto immunes et Toxiques   (France)

^c AVICENNE HOSPITAL   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e INSERM   (France)

Author keywords

Autoimmune bullous dermatoses; ELISA; Human amniotic membrane immunoblotting; Immunofluorescence

Indexed keywords

AUTOANTIBODY; BP 180 ANTIBODY; BULLOUS PEMPHIGOID ANTIGEN 1 ANTIBODY; COLLAGEN TYPE 7 ANTIBODY; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3 ANTIBODY; DESMOPLAKIN I ANTIBODY; DESMOPLAKIN II ANTIBODY; ENVOPLAKIN ANTIBODY; LAMININ; PERIPLAKIN ANTIBODY; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

AMNION; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; BULLOUS SYSTEMIC LUPUS ERYTHEMATOSUS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMOLYSIS BULLOSA ACQUISITA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MUCOUS MEMBRANE PEMPHIGOID; PARANEOPLASTIC PEMPHIGUS; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; CASE CONTROL STUDY; FLUORESCENT ANTIBODY TECHNIQUE; HAPLORHINI; IMMUNOLOGY; PROCEDURES; RAT; SKIN DISEASES, VESICULOBULLOUS;

AMNION; ANIMALS; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HAPLORHINI; HUMANS; IMMUNOBLOTTING; RATS; SKIN DISEASES, VESICULOBULLOUS;

EID: 77949779362     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09566.x     Document Type: Article

References (41)

1. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med 2007 11 : 462 481.
2. Matsumura K, Amagai M, Nishikawa T, Hashimoto T. The majority of bullous pemphigoid and herpes gestationis serum sera react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 1996 288 : 507 509.
3. Kobayashi M, Amagai M, Kuroda-Kinoshita K et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002 30 : 224 232.
4. Hamada T, Nagata Y, Tomita M et al. Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblotting analyses using bacterial recombinant proteins covering the entire molecule. Exp Dermatol 2001 10 : 256 263.
5. Yoshida M, Hamada T, Amagai M et al. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 2006 41 : 21 30.
6. Pas HH, Kloosterhuis GJ, Heeres K et al. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180. J Invest Dermatol 1997 108 : 423 429.
7. Laffitte E, Favre B, Fontao L et al. Plectin, an unusual target antigen in bullous pemphigoid. Br J Dermatol 2001 144 : 136 138.
8. Dainichi T, Kurono S, Ohyama B et al. Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A 2009 106 : 2800 2805.
9. Chan LS, Ahmed AR, Anhalt GJ et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002 138 : 370 379.
10. Lapiere JC, Woodley DT, Parente MG et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993 92 : 1831 1839.
11. Baroni A, Lanza A, Cirillo N et al. Vesicular and bullous disorders: pemphigus. Dermatol Clin 2007 25 : 597 603.
12. Ishii K, Amagai M, Hall RP et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol 1997 159 : 2010 2017.
13. Harman KE, Gratian MJ, Seed PT et al. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Clin Exp Dermatol 2000 25 : 236 240.
14. Amagai M, Tsunoda K, Zillikens D et al. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999 40 : 167 170.
15. Oursler JR, Labib RS, Ariss-Abdo L et al. Human autoantibodies against desmoplakins in paraneoplastic pemphigus. J Clin Invest 1992 89 : 1775 1782.
16. Zhu X, Zhang B. Paraneoplastic pemphigus. J Dermatol 2007 34 : 503 511.
17. Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman's disease. Br J Dermatol 2003 149 : 1143 1151.
18. Helou J, Allbritton J, Anhalt GJ. Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 1995 32 : 441 447.
19. Joly P, Richard C, Gilbert D et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000 43 : 619 626.
20. Hashimoto T, Ogawa MM, Konohana A, Nishikawa T. Detection of pemphigus vulgaris and pemphigus foliaceus antigens by immunoblotting analysis using different antigen sources. J Invest Dermatol 1990 94 : 327 331.
21. Ohata Y, Hashimoto T, Nishikawa T. Comparative study of autoantigens for various bullous skin diseases by immunoblotting using different dermo-epidermal separation techniques. Clin Exp Dermatol 1995 20 : 454 458.
22. Batteux F, Franck N, Jaffray P et al. An extract from cultured human keratinocytes that contains the major autoantigens related to autoimmune bullous skin diseases. J Clin Immunol 1997 17 : 228 233.
23. Oyama N, Bhogal BS, Carrington P et al. Human placental amnion is a novel substrate for detecting autoantibodies in autoimmune bullous diseases by immunoblotting. Br J Dermatol 2003 148 : 939 944.
24. Pas HH. Immunoblot assay in differential diagnosis of autoimmune blistering skin diseases. Clin Dermatol 2001 19 : 622 630.
25. Zillikens D, Rose PA, Balding SD et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 1997 109 : 573 579.
26. Nakatani C, Muramatsu T, Shirai T. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16a and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblotting analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins. Br J Dermatol 1998 139 : 365 370.
27. Perriard J, Jaunin F, Favre B et al. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180. J Invest Dermatol 1999 112 : 141 147.
28. Lin MS, Fu CL, Giudice GJ et al. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol 2000 115 : 955 961.
29. Skaria M, Jaunin F, Hunziker T et al. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol 2000 114 : 998 1004.
30. Kromminga A, Sitaru C, Hagel C et al. Development of an ELISA for the detection of autoantibodies to BP230. Clin Immunol 2004 111 : 146 152.
31. Balding SD, Prost C, Diaz LA et al. Mucous membrane pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 1996 106 : 141 146.
32. Schmidt E, Skrobek C, Kromminga A et al. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 2001 145 : 778 783.
33. Bédane C, McMillan JR, Balding SD et al. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol 1997 108 : 901 907.
34. Lee CW. An extract of cultured A431 cells contains major tissue antigens of autoimmune bullous diseases. Br J Dermatol 2000 143 : 821 823.
35. Engineer L, Johnson RE, Bhol KC, Ahmed AR. Bovine gingival lysate: a novel substrate for rapid diagnosis of autoimmune vesiculo-bullous diseases. A preliminary observation. Exp Dermatol 2000 9 : 271 274.
36. Champliaud MF, Lunstrum GP, Rousselle P et al. Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J Cell Biol 1996 132 : 1189 1198.
37. D'Alessio M, Zambruno G, Charlesworth A et al. Immunofluorescence analysis of villous trophoblasts: a tool for prenatal diagnosis of inherited epidermolysis bullosa with pyloric atresia. J Invest Dermatol 2008 128 : 2815 2819.
38. Amagai M, Komai A, Hashimoto T et al. Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigus. Br J Dermatol 1999 140 : 351 357.
39. Cozzani E, Kanitakis J, Nicolas JF et al. Comparative study of indirect immunofluorescence and immunoblotting for the diagnosis of autoimmune pemphigus. Arch Dermatol Res 1994 286 : 295 299.
40. Jiao D, Bystryn JC. Sensitivity of indirect immunofluorescence, substrate specificity, and immunoblotting in the diagnosis of pemphigus. J Am Acad Dermatol 1997 37 : 211 216.
41. Cozzani E, Dal Bello MG, Mastrogiacomo A et al. Antidesmoplakin antibodies in pemphigus vulgaris. Br J Dermatol 2006 154 : 624 628.